| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
5,524,000 |
| Market
Cap: |
570.02(M) |
| Last
Volume: |
19,542 |
Avg
Vol: |
40,496 |
| 52
Week Range: |
$84.55 - $168.51 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ INDUSTRIAL |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Mesa Laboratories manufactures, develops, and sells quality control products and services. Co. is organized into four segments: Sterilization and Disinfection Control Division, which provides manufactures and sells biological, chemical and cleaning indicators used to assess the effectiveness of sterilization processes; Biopharmaceutical Development Division, which develops, manufactures, and sells automated systems for protein analysis and peptide synthesis; Calibration Solutions Division, which develops, manufactures, and sells quality control and calibration products; and Clinical Genomics Division, which develops, manufactures, and sells genetic analysis tools used by labs.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
500 |
| Total Buy Value |
$0 |
$0 |
$0 |
$100,000 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
0 |
1,500 |
10,500 |
46,373 |
| Total Sell Value |
$0 |
$168,540 |
$1,317,035 |
$8,243,267 |
| Total People Sold |
0 |
1 |
3 |
8 |
| Total Sell Transactions |
0 |
1 |
5 |
25 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Sullivan John James |
Director |
– • – |
2022-06-07 |
4 |
S |
$207.76 |
$1,078,690 |
D/D |
(5,192) |
23,857 |
|
37% |
|
| Sullivan John James |
Director |
– • – |
2022-06-07 |
4 |
OE |
$70.56 |
$366,348 |
D/D |
5,192 |
29,049 |
|
- |
|
| Sullivan John James |
Director |
– • – |
2022-06-07 |
4/A |
AS |
$207.76 |
$1,078,690 |
D/D |
(5,192) |
23,857 |
|
- |
|
| Sullivan John James |
Director |
– • – |
2022-06-07 |
4/A |
OE |
$70.56 |
$366,348 |
D/D |
5,192 |
29,049 |
|
- |
|
| Sakys John V |
CFO |
• – – |
2022-04-20 |
4 |
AS |
$250.44 |
$18,032 |
D/D |
(72) |
7,514 |
|
-30% |
|
| Sakys John V |
CFO |
• – – |
2022-04-20 |
4 |
OE |
$51.85 |
$3,733 |
D/D |
72 |
7,586 |
|
- |
|
| Sakys John V |
CFO |
• – – |
2022-03-24 |
4 |
AS |
$251.15 |
$168,271 |
D/D |
(670) |
7,514 |
|
-15% |
|
| Sakys John V |
CFO |
• – – |
2022-03-23 |
4 |
AS |
$251.29 |
$233,700 |
D/D |
(930) |
8,184 |
|
-14% |
|
| Sakys John V |
CFO |
• – – |
2022-03-23 |
4 |
OE |
$51.85 |
$82,960 |
D/D |
1,600 |
9,114 |
|
- |
|
| Sullivan John James |
Director |
– • – |
2022-02-17 |
4 |
OE |
$70.56 |
$70,560 |
D/D |
1,000 |
23,857 |
|
- |
|
| Sullivan John James |
Director |
– • – |
2022-02-15 |
4 |
AS |
$259.42 |
$1,346,909 |
D/D |
(5,192) |
22,857 |
|
-21% |
|
| Sullivan John James |
Director |
– • – |
2022-02-15 |
4 |
OE |
$70.56 |
$487,368 |
D/D |
5,192 |
28,049 |
|
- |
|
| Schmieder John Bradley |
Director |
– • – |
2022-01-03 |
4 |
AS |
$327.77 |
$327,770 |
D/D |
(1,000) |
71,015 |
|
-35% |
|
| Schmieder John Bradley |
Director |
– • – |
2022-01-03 |
4 |
OE |
$97.78 |
$97,780 |
D/D |
1,000 |
72,015 |
|
- |
|
| Schmieder John Bradley |
Director |
– • – |
2021-12-16 |
4 |
A |
$0.00 |
$0 |
I/I |
19,360 |
19,360 |
|
- |
|
| Archbold Brian David |
SVP Operations |
• – – |
2021-12-14 |
4 |
S |
$325.02 |
$539,208 |
D/D |
(1,659) |
154 |
|
29% |
|
| Archbold Brian David |
SVP Operations |
• – – |
2021-12-14 |
4 |
OE |
$142.40 |
$346,090 |
D/D |
1,659 |
1,813 |
|
- |
|
| Sakys John V |
CFO |
• – – |
2021-12-10 |
4 |
AS |
$324.74 |
$570,893 |
D/D |
(1,758) |
7,514 |
|
-28% |
|
| Sakys John V |
CFO |
• – – |
2021-12-10 |
4 |
OE |
$89.70 |
$170,621 |
D/D |
1,758 |
9,272 |
|
- |
|
| Guillemin Evan |
Director |
– • – |
2021-12-02 |
4 |
S |
$310.61 |
$720,615 |
D/D |
(2,320) |
29,758 |
|
19% |
|
| Guillemin Evan |
Director |
– • – |
2021-12-02 |
4 |
OE |
$58.51 |
$212,441 |
D/D |
2,320 |
32,078 |
|
- |
|
| Sullivan John James |
Director |
– • – |
2021-11-17 |
4 |
OE |
$70.56 |
$70,560 |
D/D |
1,000 |
22,857 |
|
- |
|
| Sullivan John James |
Director |
– • – |
2021-11-15 |
4 |
AS |
$308.02 |
$1,599,240 |
D/D |
(5,192) |
21,857 |
|
-17% |
|
| Sullivan John James |
Director |
– • – |
2021-11-15 |
4 |
OE |
$89.70 |
$504,135 |
D/D |
5,192 |
27,049 |
|
- |
|
| Sakys John V |
CFO |
• – – |
2021-11-11 |
4 |
S |
$317.12 |
$317,120 |
D/D |
(1,000) |
7,514 |
|
20% |
|
176 Records found
|
|
Page 2 of 8 |
|
|
1.39 (1.37%) 
